APP669-711 (0.5 mg vial)

Product Name: APP669-711 (0.5 mg vial)

Product Number: APP-4518-v

Synonym(s): Val-Lys-Met-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val

Application: A Factor of Plasma Biomarker for Cerebral Amyloid

Salt Form: Trifluoroacetate Salt

Molecular Weight (g/mol): 4688.3

Purity: ?90.0% (HPLC)

Storage Conditions: -20 °C

Reference(s): N. Kaneko, R. Yamamoto, T. Sato, and K. Tanaka, Proc. Jpn. Acad. B, 90, 104 (2014). (Identification in plasma) N. Kaneko, A. Nakamura, Y. Washimi, T. Kato, T. Sakurai, Y. Arahata, M. Bundo, A. Takeda, S. Niida, K. Ito, K. Toba, K. Tanaka, and K. Yanagisawa, Proc. Jpn. Acad. B, 90, 353 (2014). (Correlation between APP669-711/Aβ1-42 in plasma and cerebral amyloid deposition) A. Nakamura, N. Kaneko, V.L. Villemagne, T. Kato, J. Doecke, V. Dore, C. Fowler, Q.X. Li, R. Martins, C. Rowe, T. Tomita, K. Matsuzaki, K. Ishii, K. Ishii, Y. Arahata, S. Iwamoto, K. Ito, K. Tanaka, C.L. Masters, and K. Yanagisawa, Nature(London), 554, 249 (2018). (APP669-711/Aβ1-42 in plasma as a biomarker for Alzheimer's disease) N. Kaneko, R. Yamamoto, T. Sato, and K. Tanaka, Proc. Jpn. Acad. B, 90, 104 (2014). (Identification in plasma) N. Kaneko, A. Nakamura, Y. Washimi, T. Kato, T. Sakurai, Y. Arahata, M. Bundo, A. Takeda, S. Niida, K. Ito, K. Toba, K. Tanaka, and K. Yanagisawa, Proc. Jpn. Acad. B, 90, 353 (2014). (Correlation between APP669-711/Aβ1-42 in plasma and cerebral amyloid deposition) A. Nakamura, N. Kaneko, V.L. Villemagne, T. Kato, J. Doecke, V. Dore, C. Fowler, Q.X. Li, R. Martins, C. Rowe, T. Tomita, K. Matsuzaki, K. Ishii, K. Ishii, Y. Arahata, S. Iwamoto, K. Ito, K. Tanaka, C.L. Masters, and K. Yanagisawa, Nature(London), 554, 249 (2018). (APP669-711/Aβ1-42 in plasma as a biomarker for Alzheimer's disease)

Special Note(s): For research use ONLY. Not for use on humans.